This page shows the latest drug launch news and features for those working in and with pharma, biotech and healthcare.
Encouraged and spurred on by the initial efficacy of Actemra, Kevzara’s owners are carrying out their own trials of the drug as a treatment for the novel coronavirus, with Regeneron ... 16 sites and evaluating the drug’s effect on fever and
New treatment option for patients with severe liver disease. The European subsidiary of Japanese pharma company Shionogi has announced the launch of its thrombocytopenia drug Mulpleo in the UK, offering a ... The positive recommendations of the drug were
The drug was originally being developed as a treatment for the infectious diseases Ebola and Marbug virus. ... However, despite successfully copying and manufacturing the drug, BrightGene has said it will not launch the drug until it has received
New drug due for launch in Europe in the second quarter. ... duration. The new drug made $35m in the fourth quarter following its launch in the US in October, which Tschudin said was “a great start” with 84% of retina specialists having
However, Gilead which holds all patents around the development and production of the drug – including for its development as a treatment for coronavirus. ... Although BrightGene has said it has successfully developed and manufactured copies of the drug,
This included a boost from GLP-1 agonist Ozempic (semaglutide) which has been climbing solidly since its launch, as demand increases for the drug. ... Sales of the drug reached DKK11.2bn ($1.6bn), up from DKK1.8bn last year.
More from news
Approximately 1 fully matching, plus 203 partially matching documents found.
Nexlizet, and Esperion was even able to accelerate the launch of the therapy by one month. ... While Horizon was fortunate enough to launch its bulging eye drug, Tepezza, in January 2020, the pandemic still hit at a critical time for any new drug.
Achieving launch success in an increasingly challenging commercial environment. The pharmaceutical industry is constantly evaluating opportunities to accelerate product life cycles and bring efficiencies to drug discovery, development and
However, the situation has changed dramatically since then, with Biogen preparing for a drug launch that could make aducanumab a blockbuster and reinvigorate interest in amyloid beta. ... A lot is resting on the US Food and Drug Administration’s (FDA)
Another challenge for us as agencies is to nudge our clients to involve the end user earlier and earlier in the drug development process. ... Often, we co-design material to support the use of a drug during its clinical development.
This year’s report additionally features insight from the new Cortellis Analytics – Drug Timeline &Success Rates module, an analytic that predicts the probability of launch and timeline to market for ongoing ... The company expects to launch the drug
More from intelligence
Approximately 1 fully matching, plus 17 partially matching documents found.
She joins the group following a new US office launch. Drug development consultancy, NDA Group, has appointed Alison McGregor as its principal consultant following the opening of its new US office
Chris' experience of leading companies operating in life sciences combined with his in-depth knowledge of drug discovery will be of tremendous value to the company.”. ... The Catapult will engage the UK's experienced drug discovery talent and help
Demaree was promoted from his position as executive director of oncology marketing, where he oversaw the launch of prostate cancer drug Xtandi (enzalutamide) and promotion of lung cancer therapy Tarceva (erlotinib).
Paoletti was formerly the first appointed president of GSK Oncology, where he was responsible for the overall oncology business within the firm and oversaw activities from early drug discovery through to ... clinical development, launch and life cycle
His previous roles include president of Merck US, during which time he helped to launch the hepatitis C drug Victrelis (boceprevir) and led the acquisition of ophthalmology company Inspire Pharmaceuticals.
More from appointments
Approximately 0 fully matching, plus 8 partially matching documents found.
disease drug development and launch requires a unique business model.
The COVID-19 pandemic has added a new layer of complexity to the drug development process. ... Launch timelines have been delayed and clinical trials have been postponed or suspended.
The term ‘launch excellence’ conjures up images of a traditional brand launch in which a new drug is introduced to the market. ... The rationale here makes sense – maximising your resources on a new launch will create.
After graduation, Danni interned at Novartis Pharmaceuticals on the marketing and commercial team, working on the launch of their metastatic breast cancer drug.
of drug being promoted and how this is clinically differentiated in its competitive environment. ... connections. While promotional spend on their drug Tysabri at launch was focused on specialist detailing and medical events, the promotional mix has
More from PMHub
Approximately 0 fully matching, plus 7 partially matching documents found.
We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....